drugset

drugset / Trial / NCT01012960

Opioids and Esophageal Function

NCT01012960 ↗

Phase 4 Completed 13 enrolled Region Örebro County Wyeth is now a wholly owned subsidiary of Pfizer · collab

RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to evaluate if opioid-induced effects on the pharynx and esophagus is centrally or peripherally mediated.

Timeline

Start: 2009-11
Primary completion: 2010-01
Completion: 2010-01

Publications

Savilampi J, Ahlstrand R, Magnuson A, Wattwil M. Effects of remifentanil on the esophagogastric junction and swallowing. Acta Anaesthesiol Scand. 2013 Sep;57(8):1002-9. doi: 10.1111/aas.12134. Epub 2013 May 29.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Methylnaltrexone	Other / unclassified	0.15 mg/kg	Subcutaneous

Indications